Shankar Lal Rampal Dye-Chem Ltd has announced the renewal of its comprehensive banking facility with ICICI Bank, following a board meeting conducted on February 23, 2026. The company informed stock exchanges about the key decisions taken during the meeting in compliance with SEBI regulations.

Banking Facility Renewal Details

The board of directors approved a significant renewal of the company's financial arrangements with ICICI Bank. The facility structure includes both working capital and derivative components to support the company's operational requirements.

Board Meeting Proceedings

The board meeting was conducted efficiently, lasting only 15 minutes from 3:00 PM to 3:15 PM on February 23, 2026. During this brief session, the directors addressed multiple agenda items beyond the banking facility renewal.

Key matters considered by the board included:

• Renewal of working capital facility to ₹290 million with derivative facility from ICICI Bank
• Overall facility renewal to ₹315 million including ₹25 million derivative facility
• Noting of committee minutes and decisions

Regulatory Compliance

The company promptly communicated the board meeting outcomes to both major stock exchanges - BSE Limited and National Stock Exchange of India Limited. This disclosure was made in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ensuring transparency with stakeholders and regulatory authorities.

The communication was signed by Susheel Kumar Inani, Whole Time Director (DIN: 02928254), who digitally authenticated the document on February 23, 2026, at 3:17 PM. The company trades on BSE with scrip code 542232 and on NSE with symbol SRD, under ISIN INE01NE01012.

Shankar Lal Rampal Dye-Chem Limited has completed the regulatory publication of its unaudited financial results for the quarter and nine months ended December 31, 2025. Following the Board approval on February 14, 2026, the company published its financial results in newspapers on February 16, 2026, in compliance with SEBI regulations.

Regulatory Compliance and Publication

The company fulfilled its obligations under Regulation 47 and Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, by publishing the financial results in both English and Hindi newspapers. The publication appeared in Financial Express (English) and Business Remedy (Hindi) on February 16, 2026.

Company Secretary and Compliance Officer Aditi Babel (Membership No. F13506) coordinated the newspaper publication intimation to both BSE Limited and National Stock Exchange of India Limited on February 16, 2026.

Financial Performance Highlights

The published financial results revealed the company's operational performance for the quarter ended December 31, 2025. The results demonstrate the company's continued focus on its core trading operations in dyes and chemicals.

Board Meeting and Audit Compliance

The Board of Directors, which convened on February 14, 2026, from 12:15 PM to 12:45 PM, approved the unaudited financial results along with the limited review report from statutory auditors Laxman Kumar & Associates, Chartered Accountants. The auditors, led by partner Laxman Kumar Sindhi (Membership No. 407532), issued an unmodified opinion following their review conducted in accordance with Standard on Review Engagements (SRE) 2410.

Stock Exchange Information and Business Operations

The company maintains its listing on both BSE Limited (Scrip ID: SRD, Code: 542232) and National Stock Exchange of India Limited (Symbol: SRD) with ISIN INE01NE01012. The company continues to identify trading in dyes and chemicals as its primary reportable segment under Ind AS 108 "Operating Segment" requirements.

The financial results have been prepared in accordance with Indian Accounting Standards (Ind AS) prescribed under section 133 of the Companies Act, 2013, and are available on the company's website at www.srdyechem.com as well as on stock exchange websites.